TITLE

Step up vs step down

PUB. DATE
March 2009
SOURCE
Travel Medicine Advisor;Mar2009 Supplement, p2
SOURCE TYPE
Periodical
DOC. TYPE
Article
ABSTRACT
The article compares step-up and step-down therapies as a treatment for dyspepsia. The concept of both procedures is briefly stated. A study conducted in the Netherlands showed that patients randomly treated in the step-up and step-down process achieved a 72% and 70% treatment success rate, respectively, after a 6-month period. Reportedly, both processes have the same rate of adverse effects but the step-up process was more cost-effective than its counterpart.
ACCESSION #
36576869

 

Related Articles

  • Do cost-effectiveness analyses cause you dyspepsia? Ganiats, Theodore G. // Journal of Family Practice;Jun1997, Vol. 44 Issue 6, p541 

    This article presents the editor's views on the use of decision analysis in evaluating the cost-effectiveness of diagnostic and therapeutic approaches to dyspepsia. Decision analysis is used in decision making involving complex problems, including the evaluation of dyspeptic patients. However,...

  • Questions and Answers.  // PharmacoEconomics;1998 Supplement 2, Vol. 14, p73 

    Presents questions and their answers related to diagnosis, treatment and cost of the treatment of diseases. Role of Helicobacter pylori in the pathogenesis of upper gastrointestinal disease (UGI); Studies that are being conducted to clarify the most cost-effective management of dyspepsia;...

  • Step up vs step down.  // Infectious Disease Alert;Mar2009 Pharmacology Watch, p2 

    The article discusses research being done on dyspepsia treatment. It references a study by S. V. van Zanten, published in a 2009 issue of "Lancet." The study conducted in the Netherlands focused on dyspepsia patients who were randomized to undergo treatment with an antacid, H2-receptor...

  • Step up vs step down.  // Neurology Alert;Apr2009 Pharmacology Watch, p2 

    The article examines which method is more effective for treating dyspepsia. The first is called step-down strategy, done by starting with aggressive therapy and tapering down. The second is called step-up strategy which is done by starting with antacid and progressing to more aggressive therapy....

  • Use of endoscopy in patients with dyspepsia. Vaira, Dino; Holton, John; Osborn, John; Dowsett, John; McNeil, Ian; Hatfield, Adrian // BMJ: British Medical Journal (International Edition);7/22/89, Vol. 298 Issue 6693, p237 

    Examines the patients with dyspepsia using upper gastrointestinal endoscopy. Percentage of patients with dyspepsia without ulceration who had gastritis on histological examination; Association of gastritis with campylobacter pylory; Consideration of endoscopy as unhelpful in patients with...

  • Bimatoprost/timolol of value for glaucoma in Europe.  // PharmacoEconomics & Outcomes News;4/19/2008, Issue 551, p5 

    The article discusses research being done on the use of fixed-combination therapies in open-angle glaucoma patients. It references a study by A. Hommer, M. M. Friis et al published in the April 2008 issue of "Current Medical Research and Opinion." It notes the cost-effectiveness of a fixed-dose...

  • Alexander technique + exercise good news for back pain.  // PharmacoEconomics & Outcomes News;1/10/2009, Issue 569, p3 

    The article discusses the effectiveness of Alexander technique combined with exercise for patients with chronic or recurrent back pain. A total of 579 patients were recruited to receive either normal care, massage or six or 24 lessons in Alexander technique. Exercise proved the best value on all...

  • Dyspepsia: Treatment based on endoscopy costs no more than empiric drug therapy.  // Modern Medicine;Apr96, Vol. 64 Issue 4, p34 

    Presents an abstract of the article entitled `Initial endoscopy or empirical therapy with or without testing for Helicobacter pylori for dyspepsia: A decision analysis,' by M.D. Silverstein, T. Petterson and N.J. Talley and the abstract of the editorial entitled `Diagnosing dyspepsia: Any...

  • Azathioprine.  // Reactions Weekly;9/28/2013, Issue 1471, p12 

    The article presents a case study of a 71-year-old man who developed dyspepsia and an abnormal liver function test (LFT) while being treated with azathioprine.

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics